Relation between recurrence and expression of proliferating cell nuclear antigen, sialyl Lewis X, and sialyl Lewis a in lung cancer  Jun-ichi Ogawa, MD,

Slides:



Advertisements
Similar presentations
The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations T.Bruce Ferguson, MD, Candice Lilley.
Advertisements

Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma  Hideyuki Imoto, MD, Toshihiro.
Stephen R. Broderick, MD, MPHS 
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
Ralph J. Lewis, MD  The Journal of Thoracic and Cardiovascular Surgery 
One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 
It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible  Alessandro Brunelli,
Lung cancer screening: No more excuses
Prognostic significance of histologic differentiation, carcinoembryonic antigen value, and lymphovascular invasion in stage I non–small cell lung cancer 
Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Preoperative mediastinoscopic assessment of N factors and the need for mediastinal lymph node dissection in T1 lung cancer  Takeshi Funatsu, MD, Yoshito.
Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.
A novel biomarker for the detection of esophageal adenocarcinoma
Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.
Detection of circulating tumor cells in patients with non–small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: A potential.
Tumors of the esophagogastric junction
Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy  Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.
Nael Martini, MDa, Manjit S. Bains, MDa, Michael E
Lobe-specific extent of systematic lymph node dissection for non–small cell lung carcinomas according to a retrospective study of metastasis and prognosis 
Victor van Berkel, MD, PhD 
Patterns of survival and recurrence after surgical treatment of early stage non–small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial  Stacey.
Ugo Pastorino, MD, Marc Buyse, ScD, Godehard Friedel, MD, Robert J
Propensity score–matched analysis of adjuvant chemotherapy for stage I non–small cell lung cancer  Yasuhiro Tsutani, MD, PhD, Yoshihiro Miyata, MD, PhD,
Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer  Masahiko Harada,
Influence of Cigarette Smoking on Survival and Tumor Invasiveness in Clinical Stage IA Lung Adenocarcinoma  Ryo Maeda, MD, Junji Yoshida, MD, Genichiro.
Preoperative evidence of circulating tumor cells by means of reverse transcriptase- polymerase chain reaction for carcinoembryonic antigen messenger RNA.
Esophagectomy versus endoscopic resection for patients with early-stage adenocarcinoma: Mercedes versus Tesla  Toni Lerut, MD  The Journal of Thoracic.
The prognostic significance of tumor cell detection in intraoperative pleural lavage and lung tissue cultures for patients with lung cancer  J. Buhr,
Editorial: The core of leadership
STAT3, Cten, and lung cancer: Simultaneous excitement and caution
Survival and function after sleeve lobectomy for lung cancer
The correlation between tumor size and lymphatic vessel invasion in resected peripheral stage I non-small-cell lung cancer  Yukito Ichinose, MDa, Tokujiro.
Tumor-Infiltrating Foxp3+ Regulatory T Cells are Correlated with Cyclooxygenase-2 Expression and are Associated with Recurrence in Resected Non-small.
Aditya K. Kaza, MD  The Journal of Thoracic and Cardiovascular Surgery 
Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer  Lisa M. Brown, MD, Brian.
Subclavian artery involvement by apical chest tumors: A specific indication for the transmanubrial approach  Lorenzo Spaggiari, MD, PhD, Ugo Pastorino,
Support Your Specialty
Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer  Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,
Prognostic assessment of 1310 patients with non–small-cell lung cancer who underwent complete resection from 1980 to 1993  Kunihiko Inoue, MDa, Masami.
Intermediate-Term Outcome Of Mitral Reconstruction In Cardiomyopathy
Stephen R. Broderick, MD, MPHS 
Navigating the lung for hidden treasure
Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis  Alessandro Marra, MD, PhD, Ludger Hillejan, MD,
Radiofrequency Ablation for Stage I Non-Small Cell Lung Cancer: Management of Locoregional Recurrence  Michael Lanuti, MD, Amita Sharma, MD, Henning Willers,
Time trends and survival after operations for primary lung cancer from 1976 through 1990  Hiromi Wada, MD, Fumihiro Tanaka, MD, Kazuhiro Yanagihara, MD,
The Prognostic Impact of Cigarette Smoking on Patients with Non-small Cell Lung Cancer  Ryo Maeda, MD, Junji Yoshida, MD, PhD, Genichiro Ishii, MD, PhD,
Kai Ihnken, MD  The Journal of Thoracic and Cardiovascular Surgery 
Ara K. Pridjian, MD, Edward L. Bove, MD, Flavian M. Lupinetti, MD 
Lymph Node Metastasis In Small Peripheral Adenocarcinoma Of The Lung
R. Pfitzmann, MD, M. Hummel, MD, O. Grauhan, MD, P. Waurick, MD, R
Carcinoma of the esophagus: Prognostic significance of histologic type
Thomas W. Rice, MD  The Journal of Thoracic and Cardiovascular Surgery 
O. S. Breathnach, MDa, D. J. Kwiatkowski, MD, PhDb, D. M
Superior sulcus lung tumors: Impact of local control on survival
Stage I Non-small Cell Lung Cancer: Results for Surgery in a Patterns-of-Care Study in Sydney and for High-Dose Concurrent End-Phase Boost Accelerated.
Combined Evaluation of Postoperative Serum Levels of Carcinoembryonic Antigen Less than or Equal to 2.5 ng/ml and Absence of Vascular Invasion may Predict.
Bryan M. Burt, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
Neal S Goldstein, MD  The Annals of Thoracic Surgery 
Large clinical databases for the study of lung cancer: Making up for the failure of randomized trials  Chi-Fu Jeffrey Yang, MD, Matthew G. Hartwig, MD,
Aritoshi Hattori, MD, Kenji Suzuki, MD 
Prognostic factors and long-term results after thymoma resection: A series of 307 patients  Jean-François Regnard, MDa, Pierre Magdeleinat, MDa, Christian.
Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery  Raja M. Flores, MD  The Journal.
Who should decide margin length in pulmonary excision of lung cancer?
Lobectomy Versus Limited Resection in T1N0 Lung Cancer
Samuel Kim, MD  The Journal of Thoracic and Cardiovascular Surgery 
Nael Martini, MDa, Valerie W. Rusch, MDa, Manjit S. Bains, MDa, Mark G
Presentation transcript:

Relation between recurrence and expression of proliferating cell nuclear antigen, sialyl Lewis X, and sialyl Lewis a in lung cancer  Jun-ichi Ogawa, MD, Akemi Sano, Sirosaku Koide, MD, Akira Shohtsu, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 108, Issue 2, Pages 329-336 (August 1994) DOI: 10.5555/uri:pii:S002252239470015X Copyright © 1994 Mosby, Inc. Terms and Conditions

Fig. 1 Disease-free survival according to blood vessel invasion (BVI), expression of sialyl LewisX (SLX), and proliferating cell nuclear antigen (PCNA) in adenocarcinomas. (p < 0.03: BVI (+) SLX (-, +) PCNA (+) versus BVI (+) SLX (++) PCNA (++). Fig. 1. Cont'd. Disease-free survival according to blood vessel invasion (BVI), sialyl Lewisa (CA19-9), and proliferating cell nuclear antigen (PCNA) in non-adenocarcinomas. p < 0.05: BVI(+) CA19-9 (–, +) PCNA (+) versus BVI (+) CA19-9 (++) PCNA (++). The Journal of Thoracic and Cardiovascular Surgery 1994 108, 329-336DOI: (10.5555/uri:pii:S002252239470015X) Copyright © 1994 Mosby, Inc. Terms and Conditions

Fig. 1 Disease-free survival according to blood vessel invasion (BVI), expression of sialyl LewisX (SLX), and proliferating cell nuclear antigen (PCNA) in adenocarcinomas. (p < 0.03: BVI (+) SLX (-, +) PCNA (+) versus BVI (+) SLX (++) PCNA (++). Fig. 1. Cont'd. Disease-free survival according to blood vessel invasion (BVI), sialyl Lewisa (CA19-9), and proliferating cell nuclear antigen (PCNA) in non-adenocarcinomas. p < 0.05: BVI(+) CA19-9 (–, +) PCNA (+) versus BVI (+) CA19-9 (++) PCNA (++). The Journal of Thoracic and Cardiovascular Surgery 1994 108, 329-336DOI: (10.5555/uri:pii:S002252239470015X) Copyright © 1994 Mosby, Inc. Terms and Conditions

Fig. 2 Disease-free survival in patients with recurrent tumors according to expression of proliferating cell nuclear antigen (PCNA) in adenocarcinomas. p < 0.01: PCNA (+) versus PCNA (++). Fig. 2. Cont'd Disease-free survival in the patients with recurrent tumors according to expression of proliferating cell nuclear antigen (PCNA) in nonadenocarcinomas. p < 0.01: PCNA (+) versus PCNA (++). The Journal of Thoracic and Cardiovascular Surgery 1994 108, 329-336DOI: (10.5555/uri:pii:S002252239470015X) Copyright © 1994 Mosby, Inc. Terms and Conditions

Fig. 2 Disease-free survival in patients with recurrent tumors according to expression of proliferating cell nuclear antigen (PCNA) in adenocarcinomas. p < 0.01: PCNA (+) versus PCNA (++). Fig. 2. Cont'd Disease-free survival in the patients with recurrent tumors according to expression of proliferating cell nuclear antigen (PCNA) in nonadenocarcinomas. p < 0.01: PCNA (+) versus PCNA (++). The Journal of Thoracic and Cardiovascular Surgery 1994 108, 329-336DOI: (10.5555/uri:pii:S002252239470015X) Copyright © 1994 Mosby, Inc. Terms and Conditions